Subdural haematoma (SDH) is a known complication of bone marrow transplantation (BMT). A retrospective review of 657 consecutive patients undergoing allogeneic or autologous bone marrow/stem cell transplantation at the Royal Brisbane Hospital between January 1991 and December 1998 is reported. Seventeen cases of subdural haematoma/hygroma were identified (2.6%). Eleven of these (65%) were bilateral. Four required surgical drainage, with two developing re-accumulation of SDH. All cases presented with a headache and eight of these had associated neurological complications. Diagnosis was made predominately by CT scan: however in 25% of cases definitive diagnosis could only be made in MRI studies. An association with intrathecal methorexatecontaining conditioning therapy, post lumbar puncture headache, prolonged thrombocytopenia and coagulopathy was noted. In our experience, conservative management with platelet support and correction of coagulopathy achieved resolution of subdural haematoma in most cases, with surgical intervention being reserved for neurological deterioration. Bone Marrow Transplantation (2000) 25, 549-552.
Neurological complications following bone marrow transplantation represent a significant cause of morbidity and mortality. [1] [2] [3] Autopsy series suggest an incidence of subdural haematoma (SDH) of 0% 4 to 11.9% 3 while retrospective clinical reviews have documented this complication in 2% 5 to 2.8% 2 of patients. Associations with a pre-transplant diagnosis of acute myeloid leukaemia 2 and platelet refractoriness 6 have been suggested. This report outlines our experience with 16 episodes of SDH from a stem cell transplant cohort of 657 patients and suggests an association with conditioning regimes including intra-thecal methotrexate, especially where post lumbar puncture headache occurs.
Patients and methods
We evaluated 657 consecutive patients undergoing allogeneic or autologous stem cell transplantation at the Royal Brisbane Hospital between January 1991 and December 1998. Patient demographics are outlined in Table 1 . We reviewed the records of all patients who underwent CT or MRI head scan from the time of commencement of conditioning therapy to the time of last follow-up, relapse or death.
Bone marrow or stem cells were infused a minimum of 24 h after completion of chemotherapy. Prophylaxis for acute graft-versus-host disease included standard cyclosporin methotrexate with the addition of a single dose of folinic acid, 15 mg, 24 h after each methotrexate dose (day +2, 4, 7, 12). Complete blood counts and full biochemical profiles were performed daily until stable engraftment had been achieved, coagulation profile (prothrombin time, accelerated partial thromboplastin time, thrombin clotting time and fibrinogen) were performed twice weekly, vitamin K 10 mg i.v. was administered weekly and prophylactic platelet support was given with a threshold of 20 × 10 9 /l or 50 × 10 9 /l in the setting of obvious bleeding. Heparin (5000 U twice a day) or fragmin (5000 U daily) was given for treatment of established veno-occlusive disease but was not used on a prophylactic basis. Contrast enhanced CT scans were performed on all patients with persistent headache or other significant neurological manifestations. In the absence of detectable abnormalities on CT scan an MRI head scan was performed.
Results
Sixty-four of 657 (10%) patients experienced significant neurological manifestations and underwent imaging. Pathology was present in 28 cases (44%): SDH n = 17 (including subdural hygroma in one case), intracerebral haematoma n = 4, multifocal encepholopathy n = 3, white matter changes n = 2, occipital contusion n = 1 and disseminated candidiasis producing multiple abcesses n = 1.
Characteristics of the 17 patients with demonstrable SDH are shown in Table 2 . All cases had headache, with three patients additionally developing confusion or a deteriorating state of consciousness. Bilateral SDH was present in 11 cases. CT head scan was diagnostic for 13 cases, while MRI diagnosis was required in four cases (two normal CT head scans). Sixteen had received intrathecal methotrexate as part of the conditioning regimen (13 developed a typical post-lumbar puncture headache which in three cases persisted beyond 4 days), 11 were platelet dependent while a further four had a platelet count of Ͻ50 × 10 9 /l, and seven had a recent history of anti-coagulant therapy (five heparin for treatment of veno-occlusive disease of the liver including two not receiving heparin at the time of neurological deterioration; two warfarin for treatment of pulmonary embolus and subclavian vein thrombosis). The single patient who did not receive methotrexate as a component of the conditioning regimen had an antecedent history of a minor head injury.
Initial treatment was conservative including maintenance of platelet count Ͼ50 × 10 9 /l and correction of any coagulopathy. Four patients underwent surgery for progressive neurological symptoms. Recollection of SDH occurred for two of these patients, requiring re-drainage in one case on the contralateral side of the original procedure. No patient died as a consequence of SDH with one patient left with residual neurological deficit.
Discussion
The reported incidence of SDH in post-mortem series of patients undergoing stem cell transplantation varies widely.
3,4,7 The John's Hopkins group reported no cases in a series of 78 patients, 4 while a series from the University of California found 13 cases from 109 autopsies (12%). 3 They suggested a relationship with thrombocytopenia and coagulopathy. 3 Only a single case of SDH was noted from 57 post-mortems performed at the Children's Hospital of Philadelphia. 7 The incidence of SDH in this series (2.6%) is similar to that reported in other retrospective reviews. Garrick et al 5 describe seven cases among 350 patients (2%) while a more detailed study from the Pomeranz et al 2 identified 13 cases over a 13 year period (2.7% of 471 patients). Cases were limited to patients with acute myeloid leukaemia, five had preceding post lumbar puncture headache, and nine SDHs were bilateral. Seven patients required surgical drainage (re-collection occurred in three). All patients were treated to resolution and SDH did not result in long-term morbidity or mortality. Graus et al 8 reported 11 cases of subdural haemotoma among 425 transplant recipients, noting a relationship with autologous transplantation for acute myeloid leukaemia and platelet refractoriness. Ten cases were managed conservatively with a single fatal outcome. More recently, Staudinger et al 9 performed a prospective study on 50 patients surviving beyond 30 days after transplantation. All patients had pre-transplant and day 30 CT head scans with subdural hygromas noted in nine (18%). These patients were more likely to have suffered from prolonged headache and vomiting. They noted an association with pre-transplant lumbar puncture and post-transplant arterial hypertension. All cases were managed conservatively with spontaneous resolution occurring at a median of 60 days after transplantation.
From our experience inclusion of intrathecal methotrexate in the conditioning regimen, especially with the occurrence of complicating post-lumbar puncture headache, was a major risk factor for the occurrence of SDH. A subset analysis of this group found there was a strong association in the development of a post lumbar puncture headache and subsequent clinically significant subdural haematoma (headache being the clinical endpoint). 194 patients had intrathecal methotrexate as part of the conditioning regimen. 19 of these 194 developed a post lumbar puncture headache. 14 of 19 had a clinically significant subdural haematoma, as compared to three of 175 (P value Ͻ0.0001, using Fisher's exact test) without headache.
Onset corresponded to the period of thrombocytopenia and/or coagulopathy. These patients should be identified and attempts made to maintain their platelet count above 50 × 10 9 /l, avoid anti-coagulation, consider early imaging 551 LG-NHL = low grade non-Hodgkin's lymphoma; HD = Hodgkin's disease; RAEBt = refractory anaemia excess blasts-transformation; MVA = motor vehicle accident; dec = decreased; DP = disease present; DA = disease absent.
studies (including MRI brain scan if CT study is non-diagnostic), 6 close monitoring and control of blood pressure and possibly blood patching.
Our experience suggests that a good outcome can be achieved with conservative management, with surgery reserved for neurological deterioration. Surgical intervention for these patients was effective despite the early time period post transplantation.
